Bryxta 100mg Injection

Name: Bryxta 100mg Injection
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 17845.0 INR
Availability: InStock

Price 17845.0 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Bryxta 100mg Injection Specification

Dosage Form
Injection

Salt Composition
Bevacizumab

Life Span
36 months

Origin of Medicine
India

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 vial and package insert

Brand Name
Bryxta

Indication
Solid tumors, various cancers

Drug Type
Other

Ingredients
Bevacizumab

Physical Form
Other

Function
Other

Recommended For
Cancer treatment

Dosage
100 mg per 4 ml

Dosage Guidelines
As prescribed by physician, intravenous infusion

Suitable For
Adults

Quantity
1 vial Unit

Storage Instructions
Store in refrigerator

Monoclonal Antibody
Yes

Single Use Only
Yes

Clear Solution
Yes

Strength
100 mg

Volume
4 ml

Route
Intravenous

Prescription Required
Yes

Bryxta 100mg Injection Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
100 Vials Per Month

Delivery Time
1 Week

Bryxta 100mg Injection About

Experience a monumental breakthrough in cancer treatment with Bryxta 100mg Injection, now offered at a significant price cut under our clearance sale. Boasting competitive pricing, this first-string monoclonal antibody, formulated with Bevacizumab, serves as a decorated solution for adults combating solid tumors. Each clear solution vial (100 mg/4 ml) is single-use and must be administered intravenously under prescription. Owned and manufactured in India, Bryxta excels in inhibiting angiogenesis for various cancers. Its robust shelf life, secure packaging, and precise dosing set a new standard in oncology care.

Bryxta 100mg Injection: Targeted Oncology Solution

Bryxta 100mg Injection is specifically designed for adults diagnosed with solid tumors and select cancer types. Intended for single use, this prescription medication is formulated with the monoclonal antibody Bevacizumab, delivered intravenously at 100 mg per 4 ml vial. It is recommended for use in clinical and commercial healthcare settings, playing a critical role in comprehensive anti-cancer regimens where inhibiting angiogenesis is crucial to treatment success.

Payment, Supply, and Delivery: Valuing Access and Affordability

Bryxta 100mg Injection is delivered nationwide from India with rapid turnaround times and steadfast supply capability. Our streamlined operations ensure a consistent, reliable supply at the lowest price, reflecting an exceptional valuation for healthcare facilities. Flexible payment terms can be arranged with exporters, suppliers, and distributors, guaranteeing easy access to this essential oncology medication across various healthcare sectors.

FAQ's of Bryxta 100mg Injection:

Q: How should Bryxta 100mg Injection be administered?

A: Bryxta 100mg Injection must be administered as an intravenous infusion by a qualified healthcare professional, strictly following your physician's prescribed dosage guidelines.

Q: What is the primary benefit of using Bryxta 100mg Injection?

A: Bryxta is a monoclonal antibody that inhibits angiogenesis, which helps restrict blood supply to tumors, making it a valuable treatment option for various cancers and solid tumors.

Q: When is Bryxta 100mg Injection recommended for patients?

A: This injection is typically prescribed for adult patients diagnosed with solid tumors or specific types of cancer, based on a thorough clinical evaluation by an oncologist.

Q: Where should Bryxta 100mg Injection be stored?

A: Store Bryxta 100mg Injection in a refrigerator as instructed, ensuring it remains effective until its 36-month shelf life expires.

Q: What is the physical form and packaging of Bryxta 100mg Injection?

A: Bryxta is provided as a clear, injectable solution in a single-use vial, packaged with an insert, ensuring ease of use and safety for patients and healthcare professionals.

Tell us about your requirement